Hieronder staat een reeks publicaties van Wemos door de jaren heen. Meer recente publicaties op het gebied van onze programma’s zorgpersoneel, financiering voor gezondheid en medicijnen zijn te vinden op ons kennisplatform (Wemosresources.org).
Strategie 2019-2023, jaarrekening en -overzicht 2018
Strategy 2019-2023 (Extended version)
Voorgaande jaarrapporten en beleidsplannen
Jaaroverzicht (hoogtepunten) 2018
Kijk voor jaarverslagen en strategiedocumenten uit voorgaande jaren op deze pagina
Infographics
2019 The System of Medicine Development (and what the EU and the Netherlands can do about it)
2019 Theory of Change
2019 Health Systems: what are they? What is a good health system?
2018 Financing for Health (SDG3): Shared global responsibility – an analysis of five African countries
2018 Universal Health Coverage: a pool for a plan for UHC
Zorgpersoneel
2019 Uganda’s human resources for health: paradoxes and dilemmas (advocacy brief)
2018 Landenrapport Malawi – Mind the funding gap: who is paying the health workers?
2018 Remco van de Pas, Linda Mans, Mariëlle Bemelmans, Anja Krumeich: Framing the Health Workforce Agenda Beyond Economic Growth
2018 Factsheet ‘Introduction to Health Labour Market Analysis’
2018 Factsheet ‘Human Resources for Health: Global Agreements’
2018 World Health Organization: current issues and advocacy opportunities for civil society organizations
2017 Linda Mans, Remco van de Pas, Sascha Marschang: Civil society contributions to a sustainable health workforce in the European Union (in: Public Health Panorama 2017; 3(3):357-536)
2016 Remco van de Pas, Linda Mans, e.a.: The Code of Practice and its enduring relevance in Europe and Eastern and Southern Africa
2015 HealthWorkers4All project: Collection of case studies
2015 Amy Davies en Linda Mans: Thuisbezorgd – inwonende buitenlandse zorgverleners als oplossing?
2014 HealthWorkers4All project: A health worker for everyone, everywhere! – EU booklet
2014 HealthWorkers4All project: Health workforce shortages and international mobility in the EU
2013 HealthWorkers4All project: An overview of code implementation in EU countries
2013 HealthWorkers4All project: Caring for carers – a relevant concern?
2013 HealthWorkers4All project: Zorgen voor zorgende handen – ver van ons bed?
Goed bestuur & Financiering van gezondheid
2020 Factsheet: World Bank Trust Funds and the case of the Global Financing Facility: time for a refresh?
2020 Factsheet: ‘The Global Financing Facility’
2020 Position paper: COVID-19, SSR&D e sistemas de saúde (Português)
2020 Position paper: COVID-19, SRHR and health systems
2020 A strong health system is a prerequisite for sexual and reproductive health and rights
2019 How healthy is a ‘healthy’ economy? Incompatibility between current pathways towards SDG3 and SDG8
2019 The Global Financing Facility in Tanzania
2019 The Global Financing Facility in Malawi
2019 The Global Financing Facility in Uganda
2019 The Global Financing Facility in Kenya
2019 Factsheet: ‘Fiscal space for health and four ways to increase it’
2018 Factsheet: ‘Public Finance Targets for Universal Health Coverage (UHC)’
2017 Factsheet: ‘Global Health Strategy in theorie en praktijk’
Medicijnen
2019 SOMO & Wemos: ‘Overpriced – Drugs developed with Dutch public funding’ en Samenvatting van ‘Overpriced’
2017 Ella Weggen en Corinne Hinlopen: ‘Independent clinical research: a road towards affordable & valuable medicines’
2017 Clinical trials in Africa: the cases of Egypt, Kenya, Zimbabwe and South Africa
2017 Pearl Heinemans, Irene Schipper, Patrick Durisch: ‘Transnational pharmaceutical companies’ clinical drug trials in Egypt: ethical questions in a challenging context’ in: Dirty Profits 5.
2016 ‘Industry-sponsored clinical drug trials in Egypt: ethical questions in a challenging context’
2016 Annelies den Boer en Amy Davies: ‘Clinical trials in Africa: an exploitative relationship’ in: Dirty Profits 4.
2015 Clinical Trials Realities in Zimbabwe: Dealing with Possible Unethical Research
2015 Joint briefing paper: ”Adaptive licensing’ or ‘adaptive pathways’: deregulation under the guise of earlier access’
2014 Position paper: ‘Added Therapeutic Value: European citizens should get their money’s worth’
2014 The Clinical Trials Industry in Kenya: Realities, Risks and Challenges
2013 The Clinical Trials Industry in South Africa: Ethics, Rules and Realities
2013 Pecha Kucha: Anke Tijtsma over eerlijke medicijnen
2011 Briefing paper: Protection of Clinical Trial Participants in Countries Outside the EU
2010 The Globalization of Clinical Trials: Testimonies from Human Subjects
2008 Een bittere pil: de risico’s van klinisch geneesmiddelenonderzoek in ontwikkelingslanden
2008 SOMO Briefing paper on ethics in clinical trials: Examples of unethical trials
Schadelijke stoffen
2018 Nationaal plan: hormoonverstorende stoffen in een circulaire economie
2016 Wemos: Factsheet ‘Dit moet je weten over hormoonverstorende stoffen’
2016 Wemos en WECF: ‘Maatregelen tegen hormoonverstorende stoffen: het voorbeeld van Denemarken, Zweden en Frankrijk’
2016 Annelies den Boer, Marjorie van Duursen e.a.: ‘Help hormoonverstorende stoffen de wereld uit’ in: Medisch Contact 20/2016
Monitor Internationale Gezondheidsuitdagingen
Wemos publiceert een monitor over de onderwerpen die besproken worden tijdens de belangrijkste jaarlijkse vergaderingen van de Wereldgezondheidsorganisatie: Executive Board (januari), World Health Assembly (mei) en WHO Euro (september).
2016 Juni: Monitor 69e World Health Assembly
2016 Februari: Monitor 138e vergadering Executive Board WHO
Wemos
Ellermanstraat 15-O
1114 AK Amsterdam-Duivendrecht
T +31 020 435 20 50
E info@wemos.nl
Ellermanstraat 15-O
1114 AK Amsterdam-Duivendrecht
T +31 020 435 20 50
E info@wemos.nl
